Shanghai Pharmaceuticals Holding Co., Ltd (HKG:2607)
Hong Kong · Delayed Price · Currency is HKD 12.28
+0.15 (1.24%)
Sep 30, 2025, 4:08 PM HKT
HKG:2607 Market Cap
HKG:2607 has a market cap or net worth of 66.01 billion as of September 30, 2025. Its market cap has decreased by -1.88% in one year.
Market Cap
66.01B
Enterprise Value
95.95B
Revenue
304.00B
Ranking
n/a
PE Ratio
9.92
Stock Price
12.28
Market Cap Chart
Since August 20, 2004, HKG:2607's market cap has increased from 2.31B to 66.01B, an increase of 2,756.22%. That is a compound annual growth rate of 17.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2025 | 66.01B | -10.61% |
| Dec 31, 2024 | 73.85B | 19.47% |
| Dec 29, 2023 | 61.81B | -8.98% |
| Dec 30, 2022 | 67.91B | 12.28% |
| Dec 31, 2021 | 60.49B | 7.24% |
| Dec 31, 2020 | 56.40B | 5.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 279.26B |
| Hansoh Pharmaceutical Group Company | 214.55B |
| JD Health International | 206.50B |
| WuXi Biologics | 160.93B |
| Innovent Biologics | 160.31B |
| Sino Biopharmaceutical | 144.09B |
| Akeso | 124.26B |
| Sichuan Kelun-Biotech Biopharmaceutical | 115.57B |